CANCERIQ
CancerIQ provides a precision prevention platform that empowers healthcare providers to engage patients, stratify risk and ensure adherence with the latest evidence-based strategies to get ahead of cancer. It offers a robust content library of evidence-based guidelines and risk models to help providers interpret data and navigate patients to the appropriate genetic testing, screening, or treatment interventions.
CANCERIQ
Industry:
Health Care Information Technology Medical
Founded:
2013-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.canceriq.com
Total Employee:
11+
Status:
Active
Contact:
6467084279
Total Funding:
20 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Investors List
HealthX Ventures
HealthX Ventures investment in Series B - CancerIQ
McKesson Ventures
McKesson Ventures investment in Series B - CancerIQ
Amgen Ventures
Amgen Ventures investment in Series B - CancerIQ
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series B - CancerIQ
OSF Ventures
OSF Ventures investment in Series B - CancerIQ
HealthX Ventures
HealthX Ventures investment in Series A - CancerIQ
Lightbank
Lightbank investment in Series A - CancerIQ
Impact Engine
Impact Engine investment in Series A - CancerIQ
Impact Engine
Impact Engine investment in Venture Round - CancerIQ
1776 Ventures
1776 Ventures investment in Seed Round - CancerIQ
Official Site Inspections
http://www.canceriq.com Semrush global rank: 1.16 M Semrush visits lastest month: 27.11 K
- Host name: 199.60.103.131
- IP address: 199.60.103.131
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "CancerIQ"
About Us - CancerIQ
CancerIQ also helps streamline the genetic counseling and testing process by automatically generating pedigrees, providing a marketplace where providers can order from any testing …See details»
CancerIQ - Crunchbase Company Profile & Funding
CancerIQ may be growing as evidenced by a recent partnership to integrate AI-enabled technology, which suggests an expansion of their service offerings. Additionally, the company has successfully raised $14 million, indicating …See details»
My CancerIQ | Learn Your Risk
ABOUT My CancerIQ. Built by Cancer Care Ontario, this site shows Ontarians what steps they can take to help reduce their cancer risk. More. ABOUT CANCER RISK. Learn more about factors that can increase or decrease your …See details»
CancerIQ Company Profile 2024: Valuation, Funding & Investors
CancerIQ General Information Description. Developer of a precision health technology designed for doctors to identify and manage patients at high risk for cancer. The company's platform …See details»
My CancerIQ: Learning Your Personal Cancer Risk
Nov 21, 2024 Over 875,000 My CancerIQ risk assessments have been completed since the tool launched in 2015, empowering people in Ontario to take steps to improve their health. Many …See details»
CancerIQ Platforms
CancerIQ's Manager offers tools to help providers manage patients according to their risk-based care plan, and offer ongoing engagement to reduce risk over time. ACCESS MANAGER. ANALYTICS. CancerIQ's Analytics Platform offers …See details»
Telehealth Transition White Paper - go.canceriq.com
A roadmap to kick-starting a genetic cancer screening telehealth program that will empower your organization for future-focused digital health. A roadmap to kick-starting a genetic cancer screening telehealth program that will empower your …See details»
Celebrating 10 Years of CancerIQ
Jun 23, 2023 Then in 2019, we launched CancerIQ Analytics, so all the business stakeholders behind CancerIQ had a way to quantify the clinical and financial value of this work. For the last four years, we’ve seen this product suite deliver …See details»
Letter From the CEO: Why CancerIQ is Furthering Our …
Aug 31, 2022 Letter From the CEO: Why CancerIQ is Furthering Our Investment in Tools for Genetic Counselors. Genetic counselors are an invaluable resource for early cancer detection and precision cancer prevention. Today this limited …See details»
CancerIQ | The Business Case eBook
Plus, learn what data-backed, organization-wide clinical and financial outcomes they continue to see year-over-year – and how we can help you get the same results. ... CancerIQ, Inc. The Wrigley Building 400 Michigan Avenue Suite …See details»
How CancerIQ Aligns with the Triple Aim
Current approaches to the Institute for Healthcare Improvement's T riple Aim framework have primarily focused on managing chronic conditions. However, cancer risk assessment and …See details»
The CancerIQ Difference: Services for Success
We offer every CancerIQ customer access to a full suite of services, from launch marketing and program design to workflow integration and analytics support. Our team of experts is here to …See details»
CancerIQ Officially Launches Lab Network to Increase Awareness …
Nov 19, 2020 Anchor members include Invitae, Myriad Genetics, Eurofins EGL Genetic Diagnostics, Eurofins NTD, and LabCorp. CHICAGO, November 19, 2020 — CancerIQ, an …See details»
CancerIQ Resources
CancerIQ is proud to offer precision prevention news and learning opportunities to our clinical champion community. You don't have to be our customer to take advantage – subscribe to …See details»
Preventive Oncology: An Untapped Revenue Source for Today
Plus, learn what data-backed, organization-wide clinical and financial outcomes they continue to see year-over-year – and how we can help you get the same results. ... CancerIQ, Inc. The …See details»
CancerIQ HIPAA Training
Original material and content was created by Datica Health, Inc and adapted by CancerIQ. Please email [email protected] with any questions or problems accessing the training.. HIPAA …See details»
CancerIQ for Genetics Programs & Cancer Centers
Peer-reviewed research shows CancerIQ more than doubles genetic testing uptake "Clinical workflows that combine point-of-care genetic testing with CancerIQ, the platform powering …See details»
What is Campaign-Based Risk Assessment & How Does it Drive
Join us to discover how Nebraska Medicine transformed their approach to cancer screening by implementing CancerIQ’s newest digital tools for targeted, campaign-based patient outreach. …See details»
How to Scale Your Cancer Risk Assessment Program Across the …
Jul 8, 2019 Forecast the downstream revenue opportunity using hard metrics to gain buy-in from the financial decision makers within your organization. Pair your return on investment (ROI) …See details»